Clinical Trial Update: Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation. [NA]

View source ↗

Summary

Clinical trial update for a Phase III randomized study comparing hypofractionated stereotactic radiotherapy (3x10 Gy) to historical single-dose radiosurgery (1x…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis
• Oligoprogression

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Brain Metastasis, Oligoprogression | NA | Status: RECRUITING